Pathogenesis of Multiple Sclerosis: The Eyes only See What the Mind Is Prepared to Comprehend

Annals of Neurology

Volumn 55, Issue 4, 2004, Pages 455-457

  Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; DEMYELINATION; DISEASE PREDISPOSITION; EDITORIAL; HUMAN; IMMUNE MEDIATED INJURY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEUTROPHIL CHEMOTAXIS; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL;

COMPREHENSION; HUMANS; MULTIPLE SCLEROSIS;

EID: 1642265360     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20087     Document Type: Editorial

References (26)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000;343:938-952.
2. Prineas JW. The neuropathology of multiple sclerosis. In: Koetsier JC, ed. Handbook of clinical neurology. Vol 3 Demyelinating disease. Amsterdam: Elsevier, 1985:213-257.
3. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996;13:464-468.
4. Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996;13:469-471.
5. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nat Genet 1996;13:472-476.
6. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32: 758-766.
7. Milligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis. I. Clinical effects. J Neurol Neurosurg Psychiatr 1987;50:511-515.
8. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-182.
9. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann Neurol 1996;39: 17-28.
10. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;54:458-468.
11. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons and reduced inflammation in cortical MS lesions. Ann Neurol 2001;50:389-400.
12. Dowling P, Ming X, Raval S, et al. Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology 1999;5:1676-1682.
13. Bonetti B, Raine CS. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997;42:74-84.
14. Chang A, Nishiyama A, Peterson J, et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000;20:6404-6412.
15. Trapp BD, Bo L, Mork S, et al. Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 1999;98:49-56.
16. Dobrowsky RT, Werner MH, Castellino AM, et al. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994;265:1596-1599.
17. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, et al. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383: 716-719.
18. Sanchez-Gomez MV, Alberdi E, Ibarretxe G, et al. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 2003;23: 9519-9528.
19. Bjartmar C, Kinkel RP, Kidd G, et al. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001;57:1248-1252.
20. Ludwin SK. Understanding multiple sclerosis: lessons from pathology. Ann Neurol 2000;47:691-693.
21. Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-717.
22. Barres BA, Hart IK, Coles HSR, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992;70: 31-46.
23. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72: 971-983.
24. Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-730.
25. Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;364:362.
26. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.